Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07304466
Eligibility Criteria:
Inclusion Criteria:
Patients scheduled for right lobe living donor liver transplantation with clinically significant portal hypertension (esophageal varices, thrombocytopenia (\<100,000), ascites, encephalopathy; Child-Turcotte-Pugh class B-C)
Exclusion Criteria:
* Allergy to any of the medications to be used
* Portal vein thrombosis
* Being treated with terlipressin with a diagnosis of hepatorenal syndrome
* Portopulmonary hypertension
* Acute on chronic liver failure
* Chronic renal failure (glomerular filtration rate ≤ 30%)
* Myocardial ischemia
* Uncontrolled hypertension
* Arrhythmia
* Multiple solid organ transplantation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT07304466
Study Brief:
Protocol Section:
NCT07304466